Physician profile
Gary A Cole
NPI 1437231461
$1,038.68
in general payments reported to CMS, 2019-2025
17 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $31.29 · 2021: $58.00 · 2022: $71.64 · 2023: $144 · 2024: $281 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $188.19 | 2023-2025 | Miebo, Vyzulta, Infuse |
| Tarsus Pharmaceuticals, INC. | $160.12 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $131.22 | 2023-2025 | Tryptyr, Total30, Precision 1 |
| Dompe US, INC. | $90.68 | 2024-2025 | Oxervate |
| Optos, INC. | $65.93 | 2019 | |
| Biotissue Holdings INC. | $60.89 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $60.15 | 2022-2025 | Cequa |
| Coopervision INC. | $53.47 | 2022-2025 | Myday Contact Lens |
| Novartis Pharmaceuticals Corporation | $49.99 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $46.51 | 2019-2021 | |
| Abbvie INC. | $35.75 | 2025 | |
| Topcon Healthcare, INC. | $20.01 | 2025 | |
| Thea Pharma INC. | $18.03 | 2024 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $16.14 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.15 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.72 | 2019 | |
| Kala Pharmaceuticals, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.